Aims: Right bundle branch block (RBBB) after heart transplantation (HTX) is a common finding, but its impact on post-transplant survival remains uncertain. This study investigated the post-transplant outcomes of patients with complete RBBB (cRBBB) ≤ 30 days after HTX.

Methods: This registry study analysed 639 patients receiving HTX at Heidelberg Heart Center between 1989 and 2019. Patients were stratified by diagnosis of cRBBB ≤ 30 days after HTX. Analysis included recipient and donor data, medication, echocardiographic features, graft rejections, atrial fibrillation, heart rates, permanent pacemaker implantation and mortality after HTX including causes of death.

Results: One hundred thirty-nine patients showed cRBBB ≤ 30 days after HTX (21.8%), 20 patients with pre-existing cRBBB in the donor heart (3.2%) and 119 patients with newly acquired cRBBB (18.6%). Patients with newly acquired cRBBB had a worse 1-year post-transplant survival (36.1%, P < 0.01) compared with patients with pre-existing cRBBB (85.0%) or without cRBBB (86.4%), along with a higher percentage of death due to graft failure (P < 0.01). Multivariate analysis indicated cRBBB ≤ 30 days after HTX as significant risk factor for 1-year mortality after HTX (HR: 2.20; 95% CI: 1.68-2.87; P < 0.01). Secondary outcomes showed a higher rate of an enlarged right atrium (P = 0.01), enlarged right ventricle (P < 0.01), reduced right ventricular function (P < 0.01), 30-day atrial fibrillation (P < 0.01) and 1-year permanent pacemaker implantation (P = 0.02) in patients with cRBBB after HTX.

Conclusions: Newly acquired cRBBB early after HTX is associated with increased post-transplant mortality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497214PMC
http://dx.doi.org/10.1002/ehf2.13494DOI Listing

Publication Analysis

Top Keywords

newly acquired
12
bundle branch
8
branch block
8
heart transplantation
8
post-transplant survival
8
crbbb ≤ 30 days htx
8
patients newly
8
acquired crbbb
8
patients
7
heart
5

Similar Publications

Importance: Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of private equity acquisitions of US hospitals on patient care experience.

Objective: To evaluate whether the acquisition of hospitals by private equity firms was associated with changes in measures of patient-reported experience compared with matched control hospitals from 2008 through 2019.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.

Background: Alzheimer's Disease (AD) has a long preclinical stage, in which brain metabolic alterations precede the symptoms onset. Therefore, an early and proper diagnosis of AD is essential for prevention and therapeutic evaluation. Current diagnosis and staging procedures rely on neuroimaging techniques, such as positron emission tomography (PET), which require intensity normalization to ensure the correct interpretation of the data.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Boramae Medical Center, Seoul, Dongjak, Korea, Republic of (South).

Background: Cognitive decline often follows human immunodeficiency virus (HIV) infection, yet the specific risk factors for developing Alzheimer's disease and related dementia (ADRD) in HIV patients remain elusive.

Method: To investigate the association between acquired immune deficiency syndrome (AIDS) status at the time of HIV diagnosis and the risk of ADRD, we conducted a retrospective cohort study using data from a nationwide claim database spanning 2008 to 2021. During the study period, 13,289 patients were newly diagnosed with HIV infection and were prescribed antiretroviral therapy (ART).

View Article and Find Full Text PDF

Background: Cognitive reserve (CR) in the context of Alzheimer's' disease has been widely studied, yet less is known about how CR protects against vascular brain pathologies. Here, we explored whether dietary factors might attenuate the association between magnetic resonance imaging (MRI)-derived vascular biomarkers and cognition.

Method: Seventy-one older adults (ages 60-85) were scanned using a 3-Tesla MRI Siemens Magnetom Prisma at the University of Kentucky.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

OncoProteomics Laboratory, Department of Medical Oncology, Amsterdam UMC (VUmc), Amsterdam, North Holland, Netherlands.

Background: Different pathologies can cause dementia, including Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and frontotemporal dementia. Understanding the biological mechanisms underlying these diseases is important in order to develop therapies. Here we performed cerebrospinal fluid (CSF) proteomics in AD, DLB and FTD in order to study proteomic changes and identify novel potential biomarkers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!